STAT2d
In stark reversal, FDA to reconsider removal of Eli Lilly weight loss drug from shortage list
The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...
FDA to reconsider decision barring compounded versions of Lilly weight loss drug
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
US FDA approves Pfizer's drug for rare bleeding disorder
The U.S. Food and Drug Administration approved Pfizer's once-a-week injection for the two main types of a rare bleeding ...
thecardiologyadvisor.com2d
FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C
Miplyffa is the first drug approved for treating associated neurological symptoms in adults and children 2 years and older. HealthDay News — The U.S. Food and Drug Administration has approved Miplyffa ...
thecardiologyadvisor.com2d
FDA Drug Approval Decisions Expected in November 2024
The FDA will decide on new drugs for rosacea, AADC deficiency, breast cancer, transthyretin amyloid cardiomyopathy, and biliary tract cancer.
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...